Cargando…
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe
OBJECTIVE: To examine treatment utilization patterns and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine in routine clinical practice. BACKGROUND: Clinical trials support onabotulinumtoxinA for the prophylaxis of headache in patients with chronic migraine, but real-wo...
Autores principales: | Matharu, Manjit, Pascual, Julio, Nilsson Remahl, Ingela, Straube, Andreas, Lum, Arlene, Davar, Gudarz, Odom, Dawn, Bennett, Lee, Proctor, Christina, Gutierrez, Lia, Andrews, Elizabeth, Johannes, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734384/ https://www.ncbi.nlm.nih.gov/pubmed/28758415 http://dx.doi.org/10.1177/0333102417724150 |
Ejemplares similares
-
EHMTI-0192. Onabotulinumtoxina prophylaxis in chronic migraine utilization and patient characteristics: observational study in the European Union
por: Matharu, M, et al.
Publicado: (2014) -
OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy
por: Ray, Jason C., et al.
Publicado: (2021) -
Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020) -
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
por: Winner, Paul K., et al.
Publicado: (2020) -
OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients
por: Miller, Sarah, et al.
Publicado: (2015)